The Latest: Official: Largest jackpot won by single ticket

Dollar steadies ahead of Jackson Hole meetings

Dollar steadies ahead of Jackson Hole meetings

The dollar steadied on Thursday after another politically-driven slide against the euro and yen, helped by nerves over what message Federal Reserve policymakers will send during meetings in Jackson Hole starting later in the day. The dollar's 14 percent decline against the euro this year has come courtesy of a collapse in expectations for tax cuts and other pro-growth moves by the Trump administration that weaken the case for further rises in Fed interest rates. Any harder signal on that issue from Fed chair Janet Yellen when she speaks on Friday would be liable to help the greenback.


...Read the rest of this story

Asia stocks brush off Wall St. slide after Trump's comments, dollar revives

Asia stocks brush off Wall St. slide after Trump's comments, dollar revives

Asian stocks and the dollar edged up on Thursday, shaking off the risk aversion that gripped financial markets overnight after President Donald Trump threatened to shut down the U.S. government and end the North American Free Trade Agreement. MSCI's broadest index of Asia-Pacific shares outside Japan rose 0.45 percent. Japan's Nikkei pulled back 0.3 percent, with steelmakers slumping after the Nikkei business daily reported that Toyota Motor Corp was looking to cut the price of steel supplied to component makers in the October-March period.


...Read the rest of this story

Asia stocks brush off Wall Street slide after Trump’s comments, dollar revives

Asia stocks brush off Wall Street slide after Trump's comments, dollar revives

Asian stocks and the dollar edged up on Thursday, shaking off the risk aversion that gripped financial markets overnight after President Donald Trump threatened to shut down the U.S. government and end the North American Free Trade Agreement. Japan's Nikkei pulled back 0.3 percent, with steelmakers slumping after the Nikkei business daily reported that Toyota Motor Corp was looking to cut the price of steel supplied to component makers in the October-March period.


...Read the rest of this story

New data boosts case for extended use of AstraZeneca heart drug

New data boosts case for extended use of AstraZeneca heart drug

AstraZeneca's blood-thinner Brilinta cuts the risk of cardiovascular death by 29 percent in patients with a history of past heart attacks who keep taking it beyond the standard 12-month initial period, according to new clinical trial data. The findings, to be presented at the Aug. 26-30 European Society of Cardiology congress, are from a sub-analysis of the Pegasus clinical trial, which first reported positive results in 2015. The trial studied subjects who had a heart attack within the past one to three years and was designed to prove the value of extended use of Brilinta, which is a key product for AstraZeneca.


...Read the rest of this story